INTRODUCTION {#S1}
============

Cleavage and polyadenylation (CPA) is an essential step for 3′ end maturation of almost all eukaryotic mRNAs and long noncoding RNAs (lncRNAs) transcribed by RNA polymerase II (RNAPII) ([@R45]). It is also tightly coupled with termination of transcription ([@R21]; [@R39]). The site for CPA, also known as polyadenylation (polyA) site or PAS, is defined by surrounding sequence motifs ([@R48]). In mammals, upstream PAS motifs include the A\[A/U\]UAAA hexamer and other close variants, as well as U-rich and UGUA motifs; downstream motifs include U-rich, GU-rich, and G-rich elements ([@R15]; [@R48]). Mutations weakening or strengthening the PAS have been shown to alter gene expression in several human diseases ([@R12]), highlighting the importance of PAS for gene expression.

Most eukaryotic genes harbor multiple PASs, leading to expression of alternative cleavage and polyadenylation (APA) isoforms ([@R6]; [@R13]; [@R44]). Although the majority of APA sites are located in the last exon of genes ([@R49]), a substantial fraction of PASs are located in upstream regions, mostly in introns ([@R13]; [@R50]). Intronic polyA (IPA) leads to isoforms with different coding sequences (CDSs) or truncated transcripts without apparent functions ([@R49]). APA is highly tissue specific ([@R6]; [@R53]; [@R61]) and is dynamic in cell proliferation and differentiation ([@R17]; [@R33]; [@R41]). Although still not fully understood, APA has been shown to be regulated by a variety of mechanisms ([@R49]), among which core CPA factor expression level changes appear to be quite potent ([@R22]; [@R25]; [@R31]; [@R32]; [@R57]).

The mammalian CPA complex contains more than 20 core factors ([@R29]; [@R45]) and many associated proteins ([@R46]). Some core factors form sub-complexes, including the CPA specificity factor (CPSF), the cleavage stimulation factor (CstF), cleavage factor I (CFI), and cleavage factor II (CFII). PCF11 is part of CFII and also plays a role in termination of transcription. Although yeast and mammalian PCF11 orthologs differ substantially in size (yeast and mammalian PCF11 contain 626 and \~1,600 amino acids, respectively), several protein domains are well conserved. First, both yeast and mammalian PCF11 proteins contain an N-terminal RNAPII C-terminal domain (CTD)-interacting domain (CID). The CID, which also exists in several other proteins involved in termination of transcription ([@R24]), is believed to mediate coupling of CPA with termination ([@R34]; [@R60]). Domains for interactions with Rna14 and Rna15 in yeast (CstF77 and CstF64 in mammals) and for Clp1 binding are also conserved. In addition, two zinc-binding regions of human PCF11 interact with RNA without strong specificity ([@R42]), and the corresponding regions in yeast PCF11 are critical for CPA ([@R9]; [@R56]). Both yeast and mammalian PCF11 proteins have also been implicated in mRNA nuclear export control ([@R18]; [@R52]). Consistent with PCF11's roles in CPA and termination, we previously showed that conditional ablation of *pcf11* in *S. pombe* and knockdown (KD) of *Pcf11* in mouse C2C12 cells lead to global 3′UTR lengthening through APA ([@R25]; [@R27]). Here we report that PCF11 level affects expression of genes on the basis of their size. Short and long genes are regulated by PCF11 with distinct mechanisms related to CPA. We show that this regulatory strategy is an integral part of gene expression program in cell differentiation, and PCF11 level is tightly controlled through autoregulation.

RESULTS {#S2}
=======

PCF11 Regulates Gene Expression Relevant to Cell Proliferation and Differentiation {#S3}
----------------------------------------------------------------------------------

We previously studied APA regulation by core CPA and splicing factors in mouse C2C12 myoblast cells by individual gene KD and 3′ end sequencing ([@R25]). Analysis of the same data indicated widespread gene expression changes in the KD samples ([Figure S1A](#SD1){ref-type="supplementary-material"}). Interestingly, gene expression changes in *Pcf11* KD cells showed a mild correlation with those in C2C12 differentiation (r = 0.20, Pearson correlation; [Figure S1B](#SD1){ref-type="supplementary-material"}). Because PCF11 protein is downregulated \~40% at the beginning of C2C12 differentiation ([Figure 1A](#F1){ref-type="fig"}), we wanted to examine to what extent PCF11, a CPA and termination factor, is involved in gene expression changes in C2C12 cell differentiation.

Both yeast and mammalian PCF11 proteins have been implicated in nuclear export of mRNA ([@R18]; [@R52]), raising the possibility that mRNA stability changes resulting from alternation of nuclear export may affect gene expression in *Pcf11* KD cells. We thus metabolically labeled cellular RNA with 4-thiouridine (4sU) for 15 min in control and KD cells (two small interfering RNAs \[siRNAs\], or siPcf11, leading to \~40% of KD at the protein level; [Figure 1B](#F1){ref-type="fig"}) and isolated 4sUlabeled, newly made RNA for 3′READS (3′ region extraction and deep sequencing) analysis, a deep sequencing method specialized for 3′ end analysis of poly(A)^+^ RNA ([Figure 1B](#F1){ref-type="fig"}) ([@R63]). Steady-state total RNA was used for comparison.

As with our previous data, siPcf11 treatment led to widespread mRNA expression changes in 4sU-labeled RNAs, with similar numbers of genes up- or downregulated (1,961 versus 2,030; [Figure 1C](#F1){ref-type="fig"}). Expression changes were largely consistent between newly made and steady-state RNAs (r = 0.89, Pearson correlation; [Figure 1D](#F1){ref-type="fig"}). Interestingly, using transcript abundance ratio between 4sU and total RNAs to reflect RNA decay rate, we found a widespread role of PCF11 in controlling transcript stability ([Figure S1C](#SD1){ref-type="supplementary-material"}), and there was a mild negative correlation between decay difference and gene expression change (r = −0.1, Pearson correlation; [Figure S1D](#SD1){ref-type="supplementary-material"}). This result indicates that mRNA stability alteration does play a role, albeit quite minor, in mRNA abundance changes in *Pcf11* KD cells.

Consistent with our previous result, gene expression regulation by *Pcf11* KD showed a correlation with that in C2C12 differentiation (r = 0.24 overall, r = 0.38 using significantly regulated genes; [Figure 1E](#F1){ref-type="fig"}). This correlation was also supported by Gene Ontology (GO) analysis ([Figure 1F](#F1){ref-type="fig"}), which showed similar significant terms between these two conditions. Downregulated genes were related to cell proliferation, such as "chromosome segregation," "mitotic nuclear division," "cell division," and "chromosome organization" ([Figure 1F](#F1){ref-type="fig"}; see [Figure S1E](#SD1){ref-type="supplementary-material"} for their relationship). In contrast, genes associated with morphology, adhesion, and migration (named MAM genes for simplicity), such as "cell adhesion," "locomotion," "membrane organization," and "cell morphogenesis," tended to be upregulated in both conditions ([Figure 1F](#F1){ref-type="fig"}; see [Figure S1E](#SD1){ref-type="supplementary-material"} for their relationship). Consistent with the gene expression result, we found that KD of *Pcf11* in C2C12 cells inhibited cell proliferation on the basis of a CPSE assay ([Figure 1G](#F1){ref-type="fig"}) and led to a mild (\~20%) but significant increase in cell migration rate on the basis of a scratch assay (p \< 0.05, t test; [Figure 1H](#F1){ref-type="fig"}).

Notably, despite the general correlation of gene expression changes between *Pcf11* KD and cell differentiation, muscle cell differentiation marker genes, such as *Myog* and *Myh3*, did not show altered expression after *Pcf11* KD ([Figure 1I](#F1){ref-type="fig"}). Therefore, PCF11 affects a subset of genes that are regulated in cell differentiation, and its downregulation is not sufficient to induce cell differentiation.

Gene Size Dichotomizes Gene Regulation by PCF11 {#S4}
-----------------------------------------------

To examine how PCF11 regulates gene expression, we carried out a regression analysis to identify gene features that correlated with gene expression changes. The gene features we examined included gene size, gene-to-gene distance, splicing features, nucleotide contents of different genic regions, RNA stability, and others (see [STAR Methods](#S16){ref-type="sec"} for detail). Strikingly, the size of the largest intron, overall intron size, and gene size were the most prominent features that correlated with gene expression changes in both steady-state and newly made RNA samples (R^2^ = 0.13--0.16; [Figures 2A](#F2){ref-type="fig"} and [S2A](#SD1){ref-type="supplementary-material"}). Note that the top three features were correlated with one another ([Figure S2B](#SD1){ref-type="supplementary-material"}). Consistently, the largest introns of MAM genes were markedly larger than those of other genes by more than 2-fold (p \< 1.0 × 10^−9^, Wilcoxon test; [Figure 2B](#F2){ref-type="fig"}), and those of cell proliferation genes were substantially shorter by about 50% (p \< 1.0 × 10^−3^, Wilcoxon test; [Figure 2B](#F2){ref-type="fig"}). In addition, genes with large introns (top 10%) showed significantly greater upregulation than MAM genes, and those with short introns (bottom 10%) showed significantly greater downregulation than cell proliferation genes (p \< 0.001, Kolmogorov-Smirnov \[K-S\] test; [Figure 2C](#F2){ref-type="fig"}), indicating that intron and gene size features, rather than gene functions, are the primary reason for mRNA expression changes in *Pcf11* KD cells.

PCF11 was previously shown to regulate 3′UTR size through APA ([@R25]). Indeed, by analyzing the relative expression of the two most abundant 3′UTR APA isoforms of a gene (named proximal PAS \[pPAS\] and distal PAS \[dPAS\] isoforms, respectively; [Figure 2D](#F2){ref-type="fig"}), we found that *Pcf11* KD led to global 3′UTR lengthening in both steady-state and newly made RNAs ([Figures 2E](#F2){ref-type="fig"} and [S2C](#SD1){ref-type="supplementary-material"}). The number of genes with lengthened 3′UTRs outnumbered those with shortened 3′UTRs by 2.0- or 2.4-fold ([Figures 2E](#F2){ref-type="fig"} and [S2C](#SD1){ref-type="supplementary-material"}). However, MAM and cell proliferation genes as well as genes with different intron sizes showed similar levels of 3′UTR lengthening to other genes, as measured using the relative expression difference (RED) score (dPAS versus pPAS isoforms in KD versus control cells; [Figure 2F](#F2){ref-type="fig"}). In addition, genes with lengthened 3′UTRs displayed a similar mRNA abundance change profile to genes without significant 3′UTR size changes ([Figure 2G](#F2){ref-type="fig"}), although, intriguingly, genes with shortened 3′UTRs tended to be downregulated ([Figure 2G](#F2){ref-type="fig"}; see below). Together, these results indicate that 3′UTR regulation does not play a global role in mRNA expression level changes in *Pcf11* KD cells.

PAS Strength and Gene Density Are Important for Short Gene Expression {#S5}
---------------------------------------------------------------------

We next reasoned that genes with different PAS strengths might be regulated differently in *Pcf11* KD cells. To this end, we compared sequence motifs around the last PASs of upregulated and downregulated genes, respectively, in short and long genes (bottom and top 20%, respectively). Interestingly, we found that upregulated short genes had significantly enriched UGUG motifs (GUGUGU and UGUGUG) in the downstream region of the PAS compared with downregulated short genes (−log~10~p = 10.7 and 11.9, respectively; [Figure 3A](#F3){ref-type="fig"}). In contrast, albeit consistent, this trend was much less significant with long genes (−log~10~p = 4.3 and 3.4, respectively; [Figure 3A](#F3){ref-type="fig"}). A similar result was obtained when the most used PAS in the last exon was used for analysis ([Figure S3A](#SD1){ref-type="supplementary-material"}). Because UGUG motifs are typically associated with strong PASs ([@R15]), this result indicates that the PAS strength of short genes is important for their gene expression.

Because short genes also tend to have short distances to neighboring genes ([Figure S3B](#SD1){ref-type="supplementary-material"}), one possible explanation for downregulation of short genes in *Pcf11* KD cells is transcriptional inference between neighboring genes resulting from unsuccessful CPA, especially when PASs are weak. To explore this, we divided genes into 25 groups on the basis of both gene size and distance to the nearest neighbor (NN) gene and examined gene expression changes in each group ([Figure S3C](#SD1){ref-type="supplementary-material"}). Interestingly, although distance to the NN did not appear to be relevant to regulation of long genes (top 20%), short genes (bottom 20%) with a long distance to the NN gene were less likely to be downregulated than those with a short distance ([Figure S3C](#SD1){ref-type="supplementary-material"}). This trend was also apparent when we examined the numbers of upregulated and downregulated genes in each gene group on the basis of gene size and distance to the NN ([Figure 3B](#F3){ref-type="fig"}). In addition, we found that genes previously shown to have transcriptional readthrough in stressed conditions ([@R51]) tended to be downregulated in *Pcf11* KD cells ([Figure 3C](#F3){ref-type="fig"}), further supporting the notion that short genes in high-density regions are prone to transcriptional interference among neighboring genes when CPA is weakened.

Interestingly, the relative transcriptional direction between neighboring genes, including head to head, tail to tail, head to tail, and tail to head (head being the transcription start site \[TSS\] and tail being the last PAS), did not appear to be important for gene expression changes ([Figure 3D](#F3){ref-type="fig"}), suggesting that gene density rather than transcriptional orientation is the major reason for short gene regulation by PCF11. It is thus possible that transcriptional readthrough may go beyond two adjacent genes when it happens. Thismayalso explain why genes with shortened 3′UTRs tend to be downregulated: suppressed CPA at a dPAS would lead to activation of pPAS and transcriptional readthrough at the same time. Taken together, our data indicate that short genes tend to be downregulated when PCF11 level is low, and both gene density and PAS strength are critical for their regulation.

Suppression of IPA Correlates with Upregulation of Long Genes {#S6}
-------------------------------------------------------------

We next wanted to address why genes with large introns were more likely to be upregulated in *Pcf11* KD cells. Because large introns tend to harbor PASs ([@R50]), we hypothesized that *Pcf11* KD might suppress IPA and, consequently, lead to upregulation of gene expression. To test this, we examined the relationship between gene expression changes and frequency of IPA sites in a gene as annotated in the comprehensive PAS database PolyA_DB ([@R54]). Indeed, genes with higher IPA site frequencies were more likely to be upregulated compared with genes with lower IPA site frequencies ([Figure 4A](#F4){ref-type="fig"}). Using PolyA_DB, we also found that a greater fraction of MAM genes had conserved IPA events than other genes by 25%--50%, whereas cell proliferation genes were similar to other genes ([Figure 4B](#F4){ref-type="fig"}).

We next compared IPA isoform abundance with that of isoforms using last exon PASs (named TPA isoforms; [Figure 4C](#F4){ref-type="fig"}, top) in KD and control cells. On the basis of RED scores (Δlog~2~ratio, IPA isoform versus TPA isoform in KD versus control cells), we found that IPA events were generally suppressed in *Pcf11* KD cells (negative values in all groups; [Figure 4C](#F4){ref-type="fig"}, bottom). Importantly, genes with large introns had significantly greater IPA suppression than other genes (p \< 0.01, K-S test; [Figure 4C](#F4){ref-type="fig"}, bottom). Although MAM genes as a whole were similar to other genes, those with large introns displayed significantly greater IPA suppression (p \< 0.01, K-S test; [Figure 4C](#F4){ref-type="fig"}). This trend is in good agreement with the IPA regulation during C2C12 differentiation, in which large intron-containing genes also had greater IPA suppression than other genes (p \< 0.01, K-S test; [Figure 4D](#F4){ref-type="fig"}).

We next asked what type(s) of introns tended to harbor suppressed IPA in *Pcf11* KD cells. To this end, we constructed a 2-dimensional IPA distribution map, in which all introns with detectable IPA events by 3′READS were evenly distributed in a 10 × 10 table, on the basis of intron size versus distance from IPA site to the TSS, or 5′ splice site (5′SS) strength, or 3′ splice site (3′SS) strength ([Figure 4E](#F4){ref-type="fig"}). Strikingly, we found that suppressed IPA events were highly enriched in large introns ([Figure 4E](#F4){ref-type="fig"}). Moderately large introns with very weak 5′SS (bottom 10%) also showed some enrichment of IPA suppression ([Figure 4E](#F4){ref-type="fig"}, middle, bottom row). In contrast, 3′SS strength did not show any relevance to IPA suppression by *Pcf11* KD ([Figure 4E](#F4){ref-type="fig"}, bottom). Similar patterns could be discerned for IPA suppression in C2C12 cell differentiation ([Figure 4F](#F4){ref-type="fig"}). These results indicate that intron size and 5′SS strength are determinants of IPA suppression in *Pcf11* KD cells and C2C12 cell differentiation, with intron size playing a more dominant role in regulation.

An example gene, *Fgf2* (encoding fibroblast growth factor 2), is shown in [Figure 4G](#F4){ref-type="fig"}. *Fgf2* displayed significant downregulation (3-fold) of an IPA isoform, whose PAS is in a large intron, and upregulation (1.9-fold) of a TPA isoform in *Pcf11* KD cells. Using RT-qPCR, we validated *Fgf2* IPA and TPA isoform expression changes ([Figure 4H](#F4){ref-type="fig"}). Taken together, our data indicate that decreased expression of PCF11 correlates with IPA suppression and upregulation of genes with large introns. This correlation may be important for cell differentiation, when PCF11 level is downregulated ([Figure 1A](#F1){ref-type="fig"}). Consistent with this view, we found that genes with large introns were substantially upregulated in C2C12 differentiation on the basis of our 3′READS data ([Figure 4I](#F4){ref-type="fig"}) and previous RNA sequencing (RNA-seq) data ([Figure 4J](#F4){ref-type="fig"}; [@R10]). Notably, this trend was even more conspicuous in neurogenesis ([Figure S4A](#SD1){ref-type="supplementary-material"}, note the y-axis scale difference compared with C2C12 differentiation), during which PCF11 level progressively decreased ([Figure S4B](#SD1){ref-type="supplementary-material"}).

Gene Regulation by PCF11 in Different Cell Contexts {#S7}
---------------------------------------------------

We next asked whether PCF11-mediated gene regulatory scheme can be similarly executed in other cell types. To this end, we knocked down *Pcf11* in mouse fibroblast NIH 3T3 and preadipocyte 3T3-L1 cells and carried out 3′READS and RNA-seq analyses, respectively. RNA-seq was used to ensure that our findings were not biased by the sequencing method used. Overall, gene expression changes in these two cell types after *Pcf11* KD were correlated with those in C2C12 KD cells (r = 0.46 and r = 0.34, respectively, Pearson correlation; [Figure 5A](#F5){ref-type="fig"}). Interestingly, whereas cell proliferation genes were significantly downregulated in NIH 3T3 KD cells, MAM genes were not substantially upregulated ([Figure 5B](#F5){ref-type="fig"}). In contrast, whereas MAM genes were well upregulated in 3T3-L1 cells, cell proliferation genes were not among the most significantly regulated ([Figure 5B](#F5){ref-type="fig"}). However, importantly, similar to *Pcf11* KD in C2C12 cells, largest intron size, overall intron size, and gene size were the top features that correlated with gene expression changes in both NIH 3T3 and 3T3-L1 cells ([Figure 5C](#F5){ref-type="fig"}). Therefore, although distinct sets of genes were regulated by *Pcf11* KD, the same regulatory rules applied in different cell types.

As in C2C12 cells, using 3′READS data of NIH 3T3 KD cells, we found that genes with high IPA site frequencies were more likely to be upregulated in KD cells than genes with lower IPA site frequencies ([Figure 5D](#F5){ref-type="fig"}), and IPA events in large introns and moderately large introns with weak 5′SS tended to be regulated in NIH 3T3 KD cells ([Figure 5E](#F5){ref-type="fig"}). Taken together, these data indicate that the same gene size-based rule in PCF11-mediated gene expression regulation applies in different cell contexts.

*Pcf11* Expression Is Autoregulated by IPA {#S8}
------------------------------------------

From our 3′READS data, we noticed that mouse *Pcf11* had several APA sites ([Figure 6A](#F6){ref-type="fig"}), including one located in intron 1 (named IPA site), one located in exon 8 (named internal exonic polyA \[EPA\] site), and two located in the 3′ terminal exon (named TPA sites). On the basis of PolyA_DB ([@R54]), these APA sites were all conserved across vertebrates ([Figure S5A](#SD1){ref-type="supplementary-material"}), and the isoforms were differentially expressed in different tissues ([Figure 6A](#F6){ref-type="fig"}).

The IPA site was of particular interest because intron 1 of *Pcf11* had a much higher conservation level than other introns ([Figure 6A](#F6){ref-type="fig"}), suggesting functional importance of the IPA site. The IPA isoform would have a short open reading frame (ORF) encoding only part of the CID domain. Using a reporter system, we validated the activity of IPA site and found that the site was even stronger than the two TPA sites ([Figure S5B](#SD1){ref-type="supplementary-material"}).

Interestingly, intron 1 of *Pcf11* has a very weak 5′SS (ranked at the 3rd percentile of all introns in the mouse genome), and its size is at the 75th percentile of all introns ([Figure 6B](#F6){ref-type="fig"}). This configuration would make the IPA site regulatable by PCF11 itself (see IPA distribution maps in [Figures 4E](#F4){ref-type="fig"} and [5E](#F5){ref-type="fig"}). Indeed, using RT-qPCR with primers specifically targeting IPA and TPA isoforms, we found that both TPA and IPA isoform levels were downregulated by 30% and 20%, respectively, in C2C12 cells with Pcf11 KD ([Figure 6C](#F6){ref-type="fig"}). Similar results were obtained using NIH 3T3 cells and mouse breast cancer cell line 4T1, although the degree of downregulation varied ([Figure 6C](#F6){ref-type="fig"}). Because the *Pcf11* siRNAs could target TPA isoforms only but not IPA isoforms ([STAR Methods](#S16){ref-type="sec"}), this result suggests that IPA site usage is responsive to PCF11 levels. In other words, the IPA site might be engaged in autoregulation of *Pcf11* expression.

To further examine the function of IPA site of *Pcf11*, we set out to delete the IPA site using the CRISPR/Cas9 method with two single guide RNAs (sgRNAs) targeting flanking regions of the IPA site ([Figure 6D](#F6){ref-type="fig"}). Although we were not able to isolate any clone using C2C12 cells, we confirmed one IPA site knockout clone using 4T1 cells. The clone, named IPA^*Pcf11*^-knockout (KO), showed homozygous removal of the target region on the basis of genomic PCR ([Figure 6D](#F6){ref-type="fig"}) and Sanger sequencing ([Figure S5C](#SD1){ref-type="supplementary-material"}). RT-qPCR analysis indicated a 5-fold decrease of the IPA isoform expression and a concomitant 5-fold increase of expression of downstream exons ([Figure 6E](#F6){ref-type="fig"}). Note that some cryptic PASs located in the first intron might be used after removal of the IPA site, leading to some residual transcripts detectable by RT-qPCR using IPA primers. Western blot analysis indicated a 40% increase of PCF11 protein expression in IPA^*Pcf11*^-KO cells ([Figure 6F](#F6){ref-type="fig"}). Therefore, removal of the IPA site led to substantial upregulation of full-length PCF11 mRNA and protein, supporting the notion that the IPA site plays a negative role in *Pcf11* expression.

Increased PCF11 Expression Leads to Global PAS Usage Changes {#S9}
------------------------------------------------------------

We next wanted to examine how APA and gene expression changed when PCF11 level was upregulated by 40% through IPA site removal. To this end, we subjected total cellular RNAs from wild-type (WT) and IPA^*Pcf11*^-KO cells to 3′READS analysis. We first examined 3′UTR APA on the basis of the two most abundant 3′UTR APA isoforms ([Figure 6G](#F6){ref-type="fig"}). We found that genes with shortened 3′UTRs outnumbered genes with lengthened 3′UTRs by 8.2-fold ([Figure 6G](#F6){ref-type="fig"}), indicating substantial global shortening of 3′UTRs in IPA^*Pcf11*^-KO cells. Strikingly, genes with activated IPA outnumbered those with repressed IPA by 21-fold ([Figure 6H](#F6){ref-type="fig"}), highlighting a very strong effect of PCF11 overexpression on IPA activation.

Interestingly, using IPA distribution maps, we found that in addition to intron size, distance to TSS was a very prominent feature of IPA activation in IPA^*Pcf11*^-KO cells ([Figure 6I](#F6){ref-type="fig"}, top). Consistently, the first two introns showed much greater activation of IPA than downstream introns ([Figure S5D](#SD1){ref-type="supplementary-material"}). Therefore, upregulation of PCF11 by 40% could trigger severe shortening of gene transcripts through activation of PASs close to the TSS.

Previous studies indicated widespread expression of upstream antisense RNAs (uaRNAs) near mammalian promoters ([@R5]). Bidirectionality of gene promoters has also been suggested as a driving force for new gene evolution ([@R55]). Focusing on the ±3 kb region around the TSS, we found that the PASs in both sense and antisense directions around the promoter were activated in IPA^*Pcf11*^-KO cells ([Figure 6J](#F6){ref-type="fig"}), with the uaRNA PASs being activated to a greater degree. This result indicates that PCF11 has a role in controlling uaRNA expression and potentially contributes to upstream antisense gene evolution.

In line with the notion that IPA regulates gene expression, we found that genes with a high IPA site frequency tended to have greater downregulation of gene expression in IPA^*Pcf11*^-KO cells compared with genes with a low IPA site frequency (p \< 0.001, K-S test; [Figure 6K](#F6){ref-type="fig"}). Notably, IPA^*Pcf11*^-KO cells had much slower migration and invasion rates than WT 4T1 cells (by 70%; [Figures S5E and S5F](#SD1){ref-type="supplementary-material"}), which are metastatic cancer cells with high migration and invasion capabilities, suggesting impacts of IPA activation on MAM gene functions.

Taken together, our data based on IPA^*Pcf11*^-KO cells support a negative role of the IPA site in control of PCF11 level, likely through autoregulation, and indicate that PCF11 is a master regulator of PAS usage genome-wide and modulates long gene expression through IPA.

Systematic Analysis of Long Gene Expression across Tissues {#S10}
----------------------------------------------------------

To further explore gene regulation by PCF11 in a broader context, we analyzed Genotype-Tissue Expression (GTEx) RNA-seq datasets ([@R2]), consisting of 5,032 samples from 27 human tissue types in 545 human individuals. Using the ratio of long gene expression levels to those of all genes as long gene expression index, we found an inverse correlation between long gene expression and PCF11 expression levels across 27 tissue types (r = −0.35, Pearson correlation; [Figures 7A](#F7){ref-type="fig"}). Notably, brain tissues had the lowest *PCF11* levels and were among the ones with the highest long gene expression levels ([Figure 7A](#F7){ref-type="fig"}). Using 5,032 RNA-seq samples from the tissues, we detected an overall trend that samples with high long gene expression levels tended to have low *PCF11* expression levels ([Figure 7B](#F7){ref-type="fig"}). Conversely, long gene expression levels tended to be low when PCF11 expression levels were high (overall r = −0.30, Pearson correlation; [Figure 7B](#F7){ref-type="fig"}). Therefore, our large-scale GTEx data analysis result supports the notion that PCF11 expression is coordinated with expression of long genes.

DISCUSSION {#S11}
==========

In this study, we reveal a dichotomic role of PCF11 in regulation of mRNA expression on the basis of gene size. Short genes, especially those in high-gene density regions and with weak PASs, appear to rely on PCF11 levels for expression. In contrast, long genes are regulated by PCF11 through IPA. This gene regulatory scheme, named PCF11-mediated expression regulation through IPA (PEIPA; [Figure 7C](#F7){ref-type="fig"}), is in play during cell differentiation, when genes with large introns (which tend to have functions in cell morphology, adhesion, and migration) are upregulated. Consistently, long gene expression across tissues is globally coordinated with PCF11 level. Moreover, PCF11 itself is regulated by IPA, which functions to maintain its expression level.

PEIPA {#S12}
-----

We found that MAM genes are regulated by PEIPA because they tend to have large introns. This trend appears to be conserved in all vertebrates, from humans to zebrafish ([Figure S6](#SD1){ref-type="supplementary-material"}), indicating that PEIPA is likely to be an evolutionarily conserved mechanism to regulate MAM genes. Notably, we found that genes enriched for neuronal features, such as "neurological system process" and "nervous system process," were also enriched with large introns, suggesting that PEIPA may have an important role in regulation of neuron-specific genes. This would be consistent with the low IPA isoform expression levels in brain ([@R26]; [@R47]; [@R61]) and much more conspicuous upregulation of large intron genes in neurogenesis compared with myogenesis ([Figures 4J](#F4){ref-type="fig"} and [S4A](#SD1){ref-type="supplementary-material"}). Our migration and invasion data on the basis of 4T1 cells with *Pcf11* IPA site KO also suggest a role of PCF11 in cancer development, especially in the metastatic phase when MAM gene expression is substantially changed ([@R11]). Notably, a recent pan-cancer screen of mutations in non-coding regions identified several single nucleotide variants in the promoter region of *PCF11* that are related to cancers ([@R14]), and low level PCF11 in neuroblastoma was found to be associated with spontaneous tumor regression ([@R35]).

Regulation of PCF11 {#S13}
-------------------

Our data indicate that PCF11 level is autoregulated through IPA. Given the widespread PAS usage changes in IPA^*Pcf11*^-KO cells, a tight control of PCF11 level through autoregulation appears critical for the homeostasis of CPA activity in the cell. In a sense, the strong IPA site of *Pcf11* coupled with weak 5′SS of intron 1 functions as a general sensor of global IPA activity in the cell. Notably, several other CPA factor genes have been reported to have IPA sites, such as *CSTF3* ([@R28]), *RBBP6* ([@R7]), and *PAPOLA* ([@R62]). Therefore, IPA is a common mechanism regulating CPA factor expression. The rationale may be that IPA bestows rapid regulation of CPA factor gene expression in response to CPA activity through expression of truncated transcripts encoding proteins with no functions or with dominant-negative activities (in the case of *RBBP6*). Whether these IPA events are coordinately regulated and how they are related to splicing control would be interesting to examine in the future.

Although we show autoregulation of *Pcf11* through IPA in this study, our data also indicate other mechanisms modulating PCF11 expression. Interestingly, we found a 4-fold increase of IPA isoform expression after 1 day of C2C12 differentiation ([Figure S7A](#SD1){ref-type="supplementary-material"}), whose level slightly decreased from 1 to 4 days of differentiation ([Figure S7A](#SD1){ref-type="supplementary-material"}). By contrast, TPA isoforms (two 3′UTR APA isoforms combined) showed a slight increase at the beginning of C2C12 differentiation followed by a 25% decrease after 4 days of differentiation ([Figure S7A](#SD1){ref-type="supplementary-material"}). Therefore, the IPA-to-TPA isoform ratio drastically increased at the beginning of differentiation by 2.7-fold and continued to increase to 3.7-fold after 4 days of differentiation ([Figure S7A](#SD1){ref-type="supplementary-material"}). Because IPA sites were generally suppressed in differentiated cells, opposite to the IPA regulation of *Pcf11*, other mechanism(s) must be in play for IPA regulation of *Pcf11* during differentiation. It is also worth noting that a 5-fold increase of *Pcf11* mRNA levels in IPA^*Pcf11*^-KO cells resulted only in 40% increase of protein expression, indicating additional post-transcriptional regulations.

PCF11 versus Other CPA Factors {#S14}
------------------------------

In addition to *Pcf11* KD, several other CPA factor KD samples also showed positive, albeit milder, correlation with C2C12 differentiation ([Figure S1B](#SD1){ref-type="supplementary-material"}), raising the possibility that their expression level changes may also contribute to regulation of short and long genes. This is possible because other CPA factors, like PCF11, can also globally regulate PAS usage ([@R25]). One important distinction, however, appears to be that PCF11 regulates PAS usage without apparent sequence preferences ([@R25]; [@R42]). However, in this study, by segregating genes according to size, we found that downstream UGUG motifs are important for short gene expression when PCF11 level is low. Downstream U/G-rich motifs are generally considered as binding sites for CstF-64 ([@R38]). Whether there is a selective interplay between PCF11 and CstF-64 for CPA of short genes needs to be firmly established in the future.

We found that overexpression of PCF11 in IPA^*Pcf11*^-KO cells leads to substantial APA changes with opposite directions to those in *Pcf11* KD cells. This indicates that PCF11 can singularly regulate PAS usage, and its expression in the cell might be rate limiting. Consistent with this notion, [@R20] and colleagues recently found that PCF11 protein is sub-stoichiometric to other CPA factors. Therefore, PCF11 is well suited to be a master regulator of APA. Its role appears more prominent for IPA events, perhaps because of the fast kinetics of splicing sharpens CPA regulation in introns.

PEIPA versus U1 Telescripting {#S15}
-----------------------------

The PEIPA mechanism by PCF11 is reminiscent of the U1 telescripting scheme, by which U1 inhibits intronic PASs to ensure expression of long genes ([@R3]; [@R19]; [@R36]). We previously showed that functional inhibition of U1 in C2C12 cells activated IPA sites with a 5′ to 3′ polarity ([@R25]), suggesting that IPA sites closer to the TSS are better protected by U1 than downstream ones. Our analysis of IPA^*Pcf11*^-KO cells indicates that PCF11 overexpression leads to conspicuous activation of IPA sites near the TSS ([Figure 6I](#F6){ref-type="fig"}), suggesting that PCF11 is a potent antagonist of U1. Future studies using PCF11 overexpression at different levels could potentially gauge how different PASs are regulated by these two mechanisms. On the other hand, we found that the IPA site of *Pcf11* can substantially be activated by U1 inhibition ([Figure S7B](#SD1){ref-type="supplementary-material"}), to a greater extent than the IPA site of *Cstf3*, which we previously identified ([@R28]). This indicates a crosstalk between these two mechanisms, potentially pegging PCF11 expression with U1 activity and providing a check on U1 telescripting.

STAR★METHODS {#S16}
============

CONTACT FOR REAGENT AND RESOURCE SHARING {#S18}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Bin Tian (<btian@rutgers.edu>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S19}
--------------------------------------

### Cell lines {#S20}

NIH 3T3 cells were cultured in high glucose Dulbecco's Modified Eagle Medium (DMEM) with 10% calf serum. C2C12 and 3T3-L1 cells were cultured in DMEM with 10% fetal bovine serum. C2C12 cell differentiation was induced by culturing cells in DMEM with 2% horse serum when cell confluency reached \> 95%. 4T1-luc2-GFP cells were cultured in RPMI-1640 medium with 10% fetal bovine serum. All culture media were supplemented with 100 I.U./mL penicillin and 100 μg/mL streptomycin.

METHOD DETAILS {#S21}
--------------

### siRNA transfection {#S22}

Transfection with siRNAs was carried out using Lipofectamine 3000 (Thermo Fisher Scientific) according to manufacturer's recommendations. Transfection was carried out for 32 h. Two siRNAs were used for *Pcf11*: (A) 5′-CGACAGCUAUUUCAGUAU CAATT/5′-UUGAUACUGAAAUAGCUGUCGTT; (B): 5′-GGGCAAAGAUGAAGAUGUATT/5′-UACAUCUUCAUCUUUGCCCTT. Control siRNAs were 5′-UUCUCCGAACGUGUCACGUTT/5′-ACGUGACACGUUCGGAGAATT.

### Pcf11 IPA site knockout by CRISPR/Cas9 {#S23}

To remove the IPA site of *Pcf11* gene, two single guide RNAs (sgRNAs) were used, which targeted upstream and downstream regions of the IPA site. sgRNA sequences were designed using a web tool ([http://crispr.mit.edu](http://crispr.mit.edu/)) considering on-target activity and potential off-target sites in the genome. DNA fragments containing sgRNA sequences were cloned into the PX459 plasmid. 4T1-luc2-GFP cells were transfected with the two sgRNA plasmids. Forty-eight hours after transfection, cells were subjected to selection in culture media containing 1.5 μg/ml Puromycin for three days. Live cells were seeded in a 96-well plate to ensure 0.5--1 cell/well. Cell colonies were selected for genomic DNA analysis by PCR. Sanger sequencing of PCR products was carried out to confirm the engineered site. The IPA site knockout clone was named IPA^*Pcf11*^-KO.

### Real-time quantitative PCR (qPCR) {#S24}

Total RNA was extracted using TRIzol (Thermo Fisher) and treated with Turbo DNase (Thermo Fisher). cDNA was synthesized using oligo(dT) and M-MLV reverse transcriptase with 1.5--2 μg of RNA. cDNA was then mixed with real-time PCR primers and Luna qPCR master mix (NEB). PCR was run on an Applied Biosciences StepOne Plus Real-Time PCR system. Data were analyzed using the ΔΔCt method for gene expression.

### Immunoblotting {#S25}

Total protein was extracted from cells using RIPA buffer. Protein concentration was determined using DC Protein Assay Kit (Bio-Rad). A total of 10--20 μg of protein per sample was resolved by 10% SDS-PAGE, followed by transfer to a PVDF membrane with pore size 0.45 um (Millipore) for immunoblotting. Signals on the blot after adding the ECL reagent were detected by the ChemiDoc Touch Imaging System (Bio-Rad). Quantification was carried out using the Fiji program ([@R43]). Membranes were stripped with ReBlot Plus Strong Antibody Stripping Solution (Millipore) before re-blotting.

### Isolation of newly made RNAs {#S26}

Cells were cultured in medium supplemented with 50 μM of 4-thiouridine (4sU, Sigma) for 15 min before harvest. Total RNA was extracted using TRIzol. 4sU-labeled RNAs were isolated following the protocol described in ([@R40]). Briefly, 25 μg of total RNA was biotinylated using biotin-HPDP (1 μg/μl in DMF, Thermo Fisher), and then extracted with chloroform three times and precipitated with ethanol. Biotinylated RNA was captured by Streptavidin C1 Dynabeads. The beads were washed six times before elution with DTT. Eluted RNA was precipitated with ethanol and then used for 3′READS.

### 3′READS library construction and sequencing {#S27}

The 3′READS procedure was described in ([@R63]). Briefly, Poly(A)^+^ RNA in 0.1--15 μg of total RNA was captured using 10 μl of oligo(dT)~25~ magnetic beads in 100 μl 1x binding buffer (10 mM Tris-Cl, pH7.5, 150 mM NaCl, 1 mM EDTA, and 0.05% TWEEN 20) and fragmented on the beads using 1.5 U of RNase III in 30 μl RNase III buffer (10 mM Tris-Cl pH8.3, 60 mM NaCl, 10 mM MgCl~2~, and 1 mM DTT) at 37°C for 15 min. After washing away unbound RNA fragments with binding buffer, poly(A)^+^ fragments were eluted from the beads with TE buffer (10 mM Tris-Cl, 1 mM EDTA, pH 7.5) and precipitated with ethanol, followed by ligation to 3 pmol of heat-denatured 5′ adaptor (5′-CCUUGGCACCCGAGAAUUCCANNNN) in the presence of 1 mM ATP, 0.1 μl of SuperaseIn, and 0.25 μl of T4 RNA ligase 1 in a 5 μl reaction at 22°C for 1 h. The ligation products were captured by 10 pmol of biotin-T15-(+TT)5 bound to 12 μl of Dynabeads MyOne Streptavidin C1. After washing with washing buffer (10 mM Tris-Cl pH7.5, 1 mM NaCl, 1 mM EDTA, and 0.05% TWEEN 20), RNA fragments on the beads were incubated with 0.01 U/μl of RNase H at 37°C for 30 min in 30 μl of RNase H buffer (50 mM Tris-Cl pH 7.5, 5 mM NaCl, 10 mM MgCl~2~, and 10 mM DTT). After washing with RNase H buffer, RNA fragments were eluted from the beads in elution buffer (1 mM NaCl, 1 mM EDTA, and 0.05% TWEEN 20) at 50°C, precipitated with ethanol, and then ligated to 3 pmol of heat-denatured 5′ adenylated 3′ adaptor (5′-rApp/NNNGATCGTCGGACTGTAGAACTCT GAAC/3ddC, where N is a random nucleotide and can be six Ns in some experiments) with 0.25 μl T4 RNA ligase 2 (truncated KQ version) at 22°C for 1 h in a 5 μl reaction containing 15% PEG 8000 and 0.2 μl of SuperaseIn. The ligation products were then precipitated and reverse transcribed using M-MLV reverse transcriptase, followed by PCR amplification using Phusion high-fidelity DNA polymerase and bar-coded PCR primers for 13--18 cycles. PCR products were size-selected twice with AMPure XP beads, using 0.6 volumes of beads (relative to the PCR reaction volume) to remove large DNA molecules and an additional 0.4 volume of beads to remove small DNA molecules. The eluted DNA was selected again with 1 volume of AMPure XP beads to further remove small DNA molecules. The size and quantity of the libraries were measured using a high sensitivity DNA kit on an Agilent Bioanalyzer. Libraries were sequenced on an Illumina NextSeq 500 (1 × 75 bases).

### Cell proliferation assay {#S28}

C2C12 cells in proliferating condition were treated with 0.25% Trypsin-EDTA and counted using Countess II FL Automated Cell Counter (Thermo Fisher). About 5 × 10^5^ cells were stained with CellTrace CFSE (for siPcf11- or siCtrl-treated cells) at the final concentration of 5 μM in 1 mL PBS at 37°C for 20 min. Unabsorbed dye was discarded through cell centrifugation and washing in PBS. For KD experiment, siRNAs were transfected immediately after staining. After 40\~48 hours, cells were analyzed in a BD FACScalibur system (BD Biosciences) with an excitation filter of 488 nm and emission filter of 530 nm for CellTrace CFSE.

### Cell migration assay {#S29}

Cells were cultured in growth medium (10% FBS) in a 6-well plate to reach \> 95% confluency, followed by starvation in the medium containing 0.1% serum for another 20 h. After washing the cells twice with PBS, scratches were made at the center of the plate with a 200 μl pipette tip. Cells were washed again with PBS to get rid of debris. Cell migration was monitored live for 24 h in an on-stage incubator of EVOS FL Auto Cell Imaging System (Thermo Fisher). Images were quantified and relative migration rate was calculated using the Fiji program ([@R43]).

### Transwell-based cell invasion assay {#S30}

Cells were first cultured in growth medium (10% serum) to reach \> 95% confluency, and then in starvation medium containing 0.1% serum for another 20 h. Cells were then trypsinized and placed in a transwell insert pre-coated with 1% Matrigel at 5 × 104 cells per well. Invasion assay was carried out for 92 h. Cells that went through the transwell insert were monitored by an EVOS FL Auto Cell Imaging System at ten random locations. Data were analyzed using the Fiji program ([@R43]).

### Fluorescence-activated cell sorting (FACS) analysis {#S31}

NIH 3T3 cells were transfected with pRiG or related reporter plasmids using Lipofectamine 3000. Cells were trypsinized, washed, and re-suspended in PBS 24 h after transfection. Green and red fluorescence signals for each cell were read at 530 nm and 585 nm, respectively, in a BD FACScalibur system (BD Biosciences). Non-transfected cells were used to determine background fluorescence. Log2(red fluorescence signal/green fluorescence signal) ratio was calculated for each cell.

### Processing of 3′READS data {#S32}

3′READS data were processed and analyzed as previously described ([@R63]). Briefly, the sequence corresponding to 5′ adaptor was first removed from raw 3′READS reads using Cutadapt ([@R30]). Reads with short inserts (\< 23 nt) were discarded. The remaining reads were then mapped to the mouse genome(mm9) using bowtie2 (local mode)([@R23]). The six random nucleotides at the 5′ end derived from the 3′ adaptor were removed before mapping using the setting "−5 6" in bowtie2. Reads with a mapping quality score (MAPQ) ≥ 10 were kept for further analysis. Reads with ≥ 2 non-genomic 5′Ts after alignment were called PAS reads. PASs within 24 nt from each other were clustered as previously described ([@R13]). The PAS read counts mapped to genes were normalized by the median ratio method in DESeq ([@R1]).

### Analysis of 3′READS data {#S33}

For 3′UTR APA analysis, the two most abundant APA isoforms (based on PAS reads) with PASs in the 3′UTR of the last exon were selected. For IPA analysis, all IPA PAS reads were combined and compared to those in the last exon. Significant APA events were those with relative abundance change \> 5% and p value \< 0.05 (Fisher's exact test) in at least one replicate and with consist regulation across all replicates. K-S (Kolmogorov--Smirnov) test was used to compare data distribution between samples. The aUTR size was the distance between proximal and dPASs in the 3′UTR. Relative Expression Difference (RED) was calculated as the difference in log2(ratio) of abundances of two PAS isoforms (dPAS v. pPAS) between two samples. For IPA analysis, all intronic PASs in a gene were combined. For gene expression analysis, PAS reads of each gene were summed. The expression fold changes were calculated using DEseq ([@R1]). Significance of difference was assessed by the negative binomial test in DEseq when there were replicates, or otherwise by the Fisher's exact test. Genes with expression difference greater than 20% and with a p value \< 0.05 were considered as signifcanly differentially expressed.

### Analysis of RNA-seq data {#S34}

Raw reads from RNA-seq were first trimmed for adaptor sequences by Cutadapt ([@R30]) and then mapped to the mouse genome (mm9) using STAR (v2.5.2) ([@R8]) with default parameters. The read count of the coding sequence (CDS) of each gene was summed and then normalized by the median ratio method in DESeq ([@R1]). Only genes with more than five reads in a sample were used for further analysis. GTEx data were downloaded from dbGaP (dbGaP: phs000424.v7)([@R2]). A total of 5,032 RNA-seq samples were analyzed. Long genes were the top 10% of genes based on size using RefSeq information. Long gene expression index was based on the ratio of long gene expression (TPM) median to all gene expression median. In tissues-based analysis, only the tissues with more than 20 samples were used.

### Gene ontology analysis {#S35}

Gene ontology (GO) term annotations of genes, including those of human, mouse, chicken, and zebrafish, were obtained from the Gene Ontology database ([@R4]). Very detailed terms were removed by the program OWLTools (<https://github.com/owlcollab/>). The Fisher's exact test was used to derive p values to indicate significance of association between a gene set and a GO term. GO terms associated with more than 1,000 genes were considered too generic and were discarded. To remove redundancy in reporting, each reported GO term was required to have at least 10% of genes that were not associated with another term with a more significant p value.

### Gene feature analysis {#S36}

Gene features were based on RefSeq annotations. RNA stability was based on the 4sU/total RNA ratio (after adjusting the U content in transcript), as we did previously ([@R64]). Distance of each gene to its nearest neighbor was defined by RefSeq. Transcriptional orientation of each gene was based on RefSeq. A linear regression model based on the scikit-learn program ([@R37]) was used to examine correlation between gene features and gene expression changes. The importance and contribution of each feature were assessed by its individual *R*^2^ and cumulative *R*^2^. The IPA frequency of a gene was obtained from PolyA_DB 3 ([@R54]), and was calculated as the number of IPA sites divided by the total number of PASs identified for the gene.

### Intron feature and IPA analyses {#S37}

Intron annotations were based on RefSeq database. The strengths of 5′ and 3′ splicing sites were calculated by the MaxEntScan program ([@R59]). Intron locations were grouped according to relative genic locations as first (+1), second (+2), middle ('M', not other groups), the second to the last (−2), and last (−1). Only genes with at least five introns were used for this analysis. For IPA distribution maps, intron size, distance between TSS and IPA site, 5′SS and 3′SS strengths were evenly binned based on all introns with detectable IPA sites in 3′READS samples, and were put into a 10×10 table. The number of introns with regulated IPAs in each cell was normalized to the number of all detected IPA events in the cell.

### PAS motif analysis {#S38}

We defined the ± 100 nt genomic region surrounding each PAS as the PAS region. K-mer frequencies were calculated in three subregions, including −100 to −41 nt, −40 to −1 nt, +1 to +100 nt using Biostrings (<https://rdrr.io/bioc/Biostrings/>). P values for the comparison of PASs in upregulated versus downregulated genes were based on the Fisher's exact test. The last 3′-most exon PAS and the most used PAS in the 3′-most exon were defined using the 3′READS data.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S39}
---------------------------------------

For all RT-qPCR, WB, and migration, invasion and reporter assay, all grouped data are presented as mean ± s.d.. Student's t test was used to determine statistical significance between groups, unless specified otherwise. Fisher's exact test was used to determine the significant level of APA changes. Significance of gene expression difference was assessed by the negative binomial test in DEseq when there were replicates, or otherwise by the Fisher's exact test. K-S test was used to compare the RED distributions and gene expression distributions in different gene sets. The Mann-Whitney-Wilcoxon test was used to compare expression changes among genes with different IPA frequencies or different features. When exact p values are not indicated, they are represented as follows: \*, p \< 0.05; \*\*, p \< 0.01; \*\*\*, p \< 0.001; n.s., p \> 0.05.

DATA AND SOFTWARE AVAILABILITY {#S40}
------------------------------

### Software {#S41}

All custom code and scripts used for processing of sequencing data and quantification analysis were written in Python, Perl, or R, and will be provided upon request to the Lead Contact.

### Data Resources {#S42}

Sequencing datasets generated in this study have been deposited into the GEO database under the accession number GEO: GSE115232.
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![PCF11 Regulates Gene Expression Related to Cell Differentiation\
(A) Western blot analysis of PCF11 expression during C2C12 cell differentiation. Relative levels are based on normalization to GAPDH. MYOG level indicates stage of differentiation.\
(B) Top: schematic of experimental design. Bottom: KD efficiency after 32 h of siRNA treatment.\
(C) Volcano plot showing expression changes (4sU RNA data only) in siPcf11 versus siCtrl. Significantly regulated genes (fold change \> 1.2 and p \< 0.05, DESeq analysis) are marked. Gene numbers are indicated.\
(D) Scatterplot comparing gene expression changes in 4sU versus total RNA samples. Pearson correlation coefficient (r) is indicated.\
(E) Scatterplot comparing gene expression changes in *Pcf11* KD cells versus C2C12 differentiation. Pearson correlation coefficient (r) is indicated (gray for all genes, black for significantly regulated genes in either condition). Pro, proliferating cells; Dif, differentiating cells (after 4 days).\
(F) Heatmap showing top Gene Ontology (GO) terms associated with regulated genes in *Pcf11* KD cells and C2C12 differentiation. Colors represent significance and direction of regulation as indicated.\
(G) Cell proliferation of siPcf11 and siCtrl cells as measured using a CFSE assay.\
(H) Cell migration analysis of siPcf11 and siCtrl cells by a scratch assay. Error bars are SEM on the basis of ten analyzed regions. \*\*p \< 0.05 (t test).\
(I) Expression changes of two muscle cell differentiation marker genes, *Myh3* and *Myog*, on the basis of 3′READS data. Error bars are SD.](nihms-1523290-f0002){#F1}

![PCF11 Regulates Gene Expression through Gene Size\
(A) Top features on the basis of regression analysis of gene features versus gene expression changes in siPcf11 versus siCtrl samples (total RNA). Features are sorted according to individual R^2^ value. Cumulative R^2^ value is based on a given feature together with all other features with a better individual R^2^ value. + and − denote positive and negative correlations, respectively.\
(B) The largest intron size of genes in different GO term gene groups. MAM (morphology, adhesion, and migration) and CP (cell proliferation) groups are indicated.\
(C) Gene expression changes of different gene groups in siPcf11 versus siCtrl samples. MAM and CP groups correspond to those in (B), respectively. Gene number is indicated in parenthesis, and median value is shown. \*\*\*p \< 0.001 (K-S test).\
(D) Schematic of 3′UTR APA analysis. RED, relative expression difference (pPAS versus dPAS in KD versus control samples).\
(E) 3′UTR APA changes in *Pcf11* KD cells (total RNA samples). The numbers of genes with significantly lengthened 3′UTRs (red) or shortened 3′UTRs (blue) are indicated.\
(F) 3′UTR APA RED of different gene groups in (C). n.s., not significant (K-S test).\
(G) Expression changes of genes with different types of 3′UTR regulation in (E). \*\*p \< 0.01 (K-S test).](nihms-1523290-f0003){#F2}

![Short Genes Depend on PCF11 for Expression\
(A) Enriched motifs around the last PAS of up- or downregulated genes (UP and DN, respectively) in short and long gene groups. Three sub-regions are analyzed, as indicated.\
(B) Gene number ratio of upregulated genes to downregulated genes in different gene groups on the basis of gene size and distance to the nearest neighbor. \*\*p \< 0.01, \*\*\*p \< 0.001, and n.s., not significant (Fisher's exact test).\
(C) Pan-stress readthrough genes (pan-stress DoG genes) tend to be downregulated in *Pcf11* KD cells. The number of pan-stress DoG genes is indicated. p value is based on K-S test.\
(D) Gene number ratio of upregulated genes to downregulated genes in five gene groups on the basis of distance to neighbor. There are four types of relationship between the analyzed gene (colored) and its neighbor, on the basis of relative transcriptional orientation (shown on the right, with arrows indicating direction of transcription). Only short genes are used for analysis.](nihms-1523290-f0004){#F3}

![Long Genes Are Regulated by PCF11 through Intronic Polyadenylation\
(A) mRNA expression changes of genes with different IPA site frequencies (number of IPA sites per gene) as annotated in PolyA_DB. \*\*\*p \< 0.001 (Wilcoxon test).\
(B) Percentage of genes with conserved IPA sites as annotated in PolyA_DB in different gene groups.\
(C) Top: schematic of IPA isoforms; bottom: IPA RED or Δlog~2~(IPA isoform/TPA isoform) between siPcf11 versus siCtrl samples, for different gene groups. \*\*p \< 0.01 and n.s., not significant (K-S test).\
(D) IPA RED in C2C12 differentiation. \*\*p \< 0.01 (K-S test). Dif, differentiating cells (4 days); Pro, proliferating cells.\
(E) IPA distribution maps of suppressed IPA events in *Pcf11* KD cells. Color represents ratio (log~2~) of number of observed (obs) events to number of expected (exp) events.\
(F) As in (E), except that suppressed IPA events in C2C12 differentiation are plotted.\
(G) An example gene *Fgf2*, which contains a regulated IPA site. IPA and TPA isoform expression changes on the basis of 3′READS data are indicated.\
(H) RT-qPCR analysis of IPA and TPA isoforms of *Fgf2* in *Pcf11* KD cells. Full-length *Pcf11* transcript change is also shown. Error bars represent SD. \*\*\*p \< 0.01 (t test).\
(I) Gene expression changes of different gene groups in C2C12 differentiation. Median value is shown. \*\*p \< 0.01 and \*\*\*p \< 0.001 (K-S test).\
(J) Gene expression changes of different gene sets at early stages of C2C12 differentiation (based on GEO: GSE94560). Error bars represent SD.](nihms-1523290-f0005){#F4}

![Gene Expression Regulation by PCF11 in Different Cell Contexts\
(A) Correlation of gene expression changes by *Pcf11* KD in C2C12 cells versus NIH 3T3 (left) or 3T3-L1 (right) cells. NIH 3T3 data are based on 3′READS and 3T3-L1 data on RNA-seq.\
(B) Top GO terms associated with up- or downregulated genes in NIH 3T3 and 3T3-L1 *Pcf11* KD cells.\
(C) Top gene features correlated with gene expression changes by *Pcf11* KD in NIH 3T3 and 3T3L1 cells.\
(D) mRNA expression changes in NIH 3T3 KD cells for genes with different IPA site frequencies (number of IPA sites per gene) as annotated in PolyA_DB. \*\*\*p \< 0.001 (Wilcoxon test).\
(E) IPA distribution maps for suppressed IPA events in NIH 3T3 KD cells.](nihms-1523290-f0006){#F5}

![*Pcf11* Expression Is Regulated by IPA\
(A) Schematic of mouse *Pcf11* gene. Multiple PASs are indicated. EPA, internal exonic polyadenylation; IPA, intronic polyadenylation; TPA, 3′ terminal exon polyadenylation. 3′READS data of brain, heart, and testis are shown.\
(B) Features of intron 1 compared with other introns in the mouse genome. Each feature has ten bins, and the bin containing intron 1 of *Pcf11* is highlighted in red. Distance to TSS is based on all IPA sites in PolyA_DB.\
(C) RT-qPCR analysis of IPA and TPA isoform expression in siPcf11 versus siCtrl cells. Error bars are SD on the basis of three replicates.\
(D) Top: schematic showing two sgRNAs used to remove a region flanking the IPA site. Bottom: validation of IPA site knockout (IPA^*Pcf11*^-KO) by genomic DNA PCR using primers flanking the KO region. WT, wild-type 4T1 cells.\
(E) RT-qPCR analysis of *Pcf11* isoform expression in WT and IPA^*Pcf11*^-KO cells. Error bars are SD on the basis of three replicates.\
(F) Western blot analysis of PCF11 in WT and IPA^*Pcf11*^-KO cells.\
(G) 3′UTR APA changes in IPA^*Pcf11*^-KO cells.\
(H) IPA changes in IPA^*Pcf11*^-KO cells. IPA isoforms (all combined) were compared with TPA isoforms (all combined) in analysis.\
(I) IPA distribution maps of activated IPA events in IPA^*Pcf11*^-KO cells.\
(J) Left: schematic of PASs around the transcription start site (TSS); right: metagene analysis of PAS usage around the TSS in WT and IPA^*Pcf1*1^-KO cells.\
(K) Gene expression changes in IPA^*Pcf11*^-KO cells for different groups of genes on the basis of IPA site frequency in PolyA_DB. \*\*\*p \< 0.01 (K-S test).](nihms-1523290-f0007){#F6}

![Global Analysis of PCF11 Expression versus Long Gene Expression across Human Tissues\
(A) Scatterplot showing correlation between long gene expression and *PCF11* expression in 27 human tissues on the basis of GTEx data. Pearson correlation coefficient (r) and its p value are shown.\
(B) Heatmap showing correlation between long gene expression and *PCF11* expression on the basis of 5,032 GTEx samples. Obs, observed number of samples; Exp, expected number of samples based on the average of all samples.\
(C) A model summarizing PCF11-mediated gene expression regulation through IPA (PEIPA).](nihms-1523290-f0008){#F7}

  REAGENT or RESOURCE                                                                                                                SOURCE                                        IDENTIFIER
  ---------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------- ------------------------------------------------------------------
  Antibodies                                                                                                                                                                       
  Mouse anti-PCF11                                                                                                                   Santa Cruz Biotechnology                      Cat\# sc-514158
  Mouse anti-Myogenin                                                                                                                Santa Cruz Biotechnology                      Cat\# sc-12732; RRID: AB_627980
  Mouse anti-GAPDH                                                                                                                   Santa Cruz Biotechnology                      Cat\# sc-47724; RRID: AB_627678
  Mouse anti-β-tubulin                                                                                                               Developmental Studies Hybridoma Bank (DSHB)   Cat\# E7; RRID: AB_528499
  m-IgGκ BP-HRP                                                                                                                      Santa Cruz Biotechnology                      Cat\# sc-516102; RRID: AB_2687626
  Chemicals, Peptides, and Recombinant Proteins                                                                                                                                    
  Phosphate buffered saline (PBS)                                                                                                    Lab made                                      N/A
  Dulbecco's Modified Eagle Medium (DMEM)                                                                                            Lab made                                      N/A
  RPMI-1640                                                                                                                          Lab made                                      N/A
  Bovine Calf Serum (CS)                                                                                                             Sigma-Aldrich                                 Cat\# 12133C-500ML
  Fetal Bovine Serum (FBS)                                                                                                           Atlanta biologicals                           Cat\# S11550
  Horse serum                                                                                                                        Sigma-Aldrich                                 Cat\# H1138--500ML
  Penicillin/Streptomycin                                                                                                            GIBCO                                         Cat\# 15140--122
  Lipofectamine 3000                                                                                                                 Thermo Fisher Scientific                      Cat\# L3000015
  TRIzol Reagent                                                                                                                     Thermo Fisher Scientific                      Cat\# 15596018
  Oligo d(T)~25~ Magnetic Beads                                                                                                      NEB                                           Cat\# S1419S
  Adenosine 5′-Triphosphate (ATP)                                                                                                    NEB                                           Cat\# P0756S
  SUPERase● In RNase Inhibitor (20 U/μL)                                                                                             Thermo Fisher Scientific                      Cat\# AM2694
  NEBNext RNase III RNA Fragmentation Module                                                                                         NEB                                           Cat\# E6146
  T4 RNA Ligase 1                                                                                                                    NEB                                           Cat\# M0204S
  T4 RNA Ligase 2, truncated KQ                                                                                                      NEB                                           Cat\# M0373S
  TURBO DNA-free Kit                                                                                                                 Thermo Fisher Scientific                      Cat\# AM1907
  M-MLV Reverse transcriptase                                                                                                        Promega                                       Cat\# M1705
  Phusion High-Fidelity DNA Polymerase                                                                                               NEB                                           Cat\# M0530S
  Q5 High-Fidelity DNA Polymerase                                                                                                    NEB                                           Cat\# M0491S
  Dynabeads MyOne Streptavidin C1                                                                                                    Thermo Fisher Scientific                      Cat\# 65001
  RNase H                                                                                                                            Epicenter                                     Cat\# R52250
  T4 Polynucleotide Kinase                                                                                                           NEB                                           Cat\# M0201S
  Shrimp Alkaline Phosphatase (rSAP)                                                                                                 NEB                                           Cat\# M0371S
  5′ adaptor: 5′-CCUUGGCACCCGAGAAU UCCANNNN                                                                                          Sigma-Aldrich                                 N/A
  DNA/LNA oligo: biotin-TTTTTTTTTTTTTTT+ TT+TT+TT+TT+TT, where "+T" denotes LNA                                                      Exiqon                                        N/A
  5′ adenylated 3′ blocked 3′ adaptor with degenerated nucleotides: 5′-rApp/NNNNGATCGTCGGACTGTA GAACTCTGAAC/3ddC                     Bioo Scientific                               N/A
  Reverse transcription primer: 5′-GTTCAGA GTTCTACAGTCCGACGATC                                                                       Sigma-Aldrich                                 N/A
  Reverse PCR primer (GX3): 5′-AATGATACGGCGACC ACCGAGATCTACACGTTCAGAGTTCTACAGTCCGA                                                   Sigma-Aldrich                                 N/A
  Indexed forward PCR primers (index region in bracket): 5′-CAAGCAGAAGA CGGCATACGAGAT\[NNNNNN\] GTGACTGGAGTT CCTTGGCACCCGAGAATTCCA   Sigma-Aldrich                                 N/A
  AMPure XP beads                                                                                                                    Beckman Coulter                               Cat\# A63881
  Agilent RNA 6000 Pico Kit                                                                                                          Agilent Technologies                          Cat\# 5067--1513
  Critical Commercial Assays                                                                                                                                                       
  High Sensitivity DNA analysis kit                                                                                                  Agilent Technologies                          Cat\# 5067--4626
  Luna Universal qPCR master mix                                                                                                     NEB                                           Cat\# M3003
  NEBNext Magnesium RNA Fragmentation Module                                                                                         NEB                                           Cat\# E6150S
  CellTrace CFSE Cell Proliferation Kit, for flow cytometry                                                                          Thermo Fisher Scientific                      Cat\# C34554
  Deposited Data                                                                                                                                                                   
  3′READS data                                                                                                                       This study                                    GEO: GSE115232
  RNA-seq data                                                                                                                       This study                                    GEO: GSE115232
  Experimental Models: Cell Lines                                                                                                                                                  
  Mouse: NIH 3T3 cells                                                                                                               ATCC                                          Cat\# CRL-1658; RRID: CVCL_0594
  Mouse: C2C12 cells                                                                                                                 ATCC                                          Cat\# CRL-1772; RRID: CVCL_0188
  Mouse: 3T3-L1 cells                                                                                                                ATCC                                          Cat\# CL-173; RRID: CVCL_0123
  Mouse: 4T1-luc2-GFP                                                                                                                Perkin Elmer                                  Cat\# 128090; RRID: CVCL_5J28
  Mouse: 4T1-IPA^*Pcf11*^-KO                                                                                                         Generated in this study                       N/A
  Recombinant DNA                                                                                                                                                                  
  Plasmid: PX459                                                                                                                     Addgene                                       Cat\# 62988; RRID: Addgene_62988
  Plasmid: PX459-mPcf11-IPA-g1                                                                                                       Cloned in this study                          N/A
  Plasmid: PX459-mPcf11-IPA-g2                                                                                                       Cloned in this study                          N/A
  Plasmid: pRiG                                                                                                                      Cloned and stored in lab                      N/A
  Plasmid: pRiG-AD                                                                                                                   Cloned and stored in lab                      N/A
  Plasmid: pRiG-Pcf11 Ctrl-seq                                                                                                       Cloned in this study                          N/A
  Plasmid: pRiG- Pcf11 IPA site                                                                                                      Cloned in this study                          N/A
  Plasmid: pRiG- Pcf11 pPAS                                                                                                          Cloned in this study                          N/A
  Plasmid: pRiG- Pcf11 dPAS                                                                                                          Cloned in this study                          N/A
  Oligonucleotides (See [Tables S2 and S3](#SD1){ref-type="supplementary-material"})                                                                                               
  Software and Algorithms                                                                                                                                                          
  FIJI                                                                                                                               [@R43]                                        <https://imagej.net/Fiji>
  Primer-BLAST                                                                                                                       [@R58]                                        <https://www.ncbi.nlm.nih.gov/tools/primer-blast/>
  Prism version 7.0a for Mac                                                                                                         GraphPad Software                             N/A
  Cutadapt                                                                                                                           [@R30]                                        <http://cutadapt.readthedocs.io/en/stable/guide.html>
  Bowtie2                                                                                                                            [@R23]                                        <http://bowtie-bio.sourceforge.net/bowtie2/index.shtml>
  DESeq & DEXSeq                                                                                                                     [@R1]                                         <https://bioconductor.org/packages/devel/bioc/html/DESeq.html>
  STAR (v2.5.2)                                                                                                                      [@R8]                                         <https://github.com/alexdobin/STAR>
  Scikit-learn                                                                                                                       [@R37]                                        <http://scikit-learn.org/stable/index.html>
  MaxEntScan                                                                                                                         [@R59]                                        <http://genes.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html>
  Other data sets                                                                                                                                                                  
  KD of core CPA and splicing factors (3′READS)                                                                                      [@R25]                                        GEO: GSE11415
  Transcriptional profiling of longitudinal changes during neurogenesis (RNA-seq)                                                    [@R16]                                        SRA: SRP017778
  Genotype-Tissue Expression Project (GTEx)                                                                                          [@R2]                                         dbGaP: phs000424.v7
  Early stages of C2C12 differentiation (RNA-seq)                                                                                    [@R10]                                        GEO: GSE94560
  Pan-readthrough genes induced by stress (gene set)                                                                                 [@R51]                                        GEO: GSE98906

###### Highlights

-   PCF11 regulates mRNA expression on the basis of gene size

-   Genes with large introns are regulated by PCF11 through intronic polyadenylation

-   PCF11 controls its own gene expression through an intronic polyadenylation site

-   Long gene and PCF11 expression levels are inversely correlated globally
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